
Sign up to save your podcasts
Or


On the final day of ECTRIMS 2025 in Barcelona, the spotlight turned to MS treatment, including long-awaited clinical trial results. Dr. Sharmilee Gnanapavan, Consultant Neurologist at Barts Health and Princess Alexandra Hospital NHS Trust (UK), joins host Brett Drummond to reflect on key takeaways from the 41st Congress and what the MS community might look forward to at MSToronto 2026.
By The European Committee for Treatment and Research in Multiple Sclerosis4.5
22 ratings
On the final day of ECTRIMS 2025 in Barcelona, the spotlight turned to MS treatment, including long-awaited clinical trial results. Dr. Sharmilee Gnanapavan, Consultant Neurologist at Barts Health and Princess Alexandra Hospital NHS Trust (UK), joins host Brett Drummond to reflect on key takeaways from the 41st Congress and what the MS community might look forward to at MSToronto 2026.

299 Listeners

53 Listeners

28,143 Listeners

113,121 Listeners

150 Listeners

898 Listeners

51 Listeners

5,217 Listeners

6,097 Listeners

125 Listeners

2,131 Listeners

80 Listeners